-
Aug 15, 2022, 15:06
by
Molly McGrath
American Society of Addiction Medicine (ASAM) and the California Society of Addiction Medicine (CSAM) sent a letter to Governor Gavin Newson urging that he sign SB 57 into law. This life-saving legislation would allow the City and County of San Francisco, the City and County of Los Angeles, and the City of Oakland to authorize overdose prevention sites (OPS).
Full story
-
Aug 3, 2022, 13:39
by
Bob Davis
The comments address exaggerated narratives about potential unintended effects of creating an uncontrolled illicit market for menthol cigarettes and flavored cigars
Full story
-
Aug 1, 2022, 10:58
by
Bob Davis
Nation’s leading medical society of addiction specialist physicians and other clinicians and associated professionals in the field of addiction medicine issues second in series of statements reflecting ASAM’s effort to recognize, understand, and counteract systemic racism.
Full story
-
Jul 19, 2022, 16:26
by
Bob Davis
ASAM and a host of leading New York and national organizations wrote to Senator Chuck Schumer on July 13, 2022, to support civil monetary penalty authority for the US Department of Labor (USDOL) to enforce the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA).
Full story
-
Jul 15, 2022, 08:36
by
Bob Davis
ASAM Level of Care Certification Rating Elements Update Addresses the Need for Continuous Process Improvement for programs that achieve certification and recertification.
Full story
-
Jul 13, 2022, 10:02
by
Bob Davis
On July 13, ASAM sent a letter to Senators Patty Murray and Richard Burr, Chair and Ranking Member of the Senate Committee on Health, Education, Labor and Pensions, respectively, in strong support for concurrent passage of S. 2235/H.R. 2067, the Medication Access and Training Expansion (MATE) Act of 2021, and S. 445/ H.R. 1384, the Mainstreaming Addiction Treatment (MAT) Act of 2021.
Full story
-
Jul 7, 2022, 17:32
by
Bob Davis
Full story
-
Jul 7, 2022, 12:01
by
Bob Davis
The 2022 state legislative sessions have been some of the busiest in recent memory. To review what transpired and its implications for the field of addiction medicine, ASAM assembled a first-of-its-kind state legislative recap.
Full story
-
Jul 7, 2022, 08:15
by
Bob Davis
On June 27th, ASAM joined a Coalition of Whole Health letter to Centers for Medicare & Medicaid Services (CMS).
Full story
-
Jun 30, 2022, 10:00
by
Bob Davis
On June 30th, the House Appropriations Committee approved the fiscal year (FY) 2023 Labor, Health and Human Services, Education, and Related Agencies bill.
Full story
-
Jun 27, 2022, 10:27
by
Bob Davis
On June 23rd, the Oregon Society of Addiction Medicine (ORSAM) sent a letter supporting Oregon’s 1115 waiver application for expanded Medicaid coverage in correctional settings. If approved, ORSAM emphasized the importance of ensuring that evidence-based addiction treatment is available in all correctional facilities throughout the state.
Full story
-
Jun 22, 2022, 18:30
by
Bob Davis
The Restoring Hope for Mental Health and Well-Being Act of 2022 (H.R. 7666) includes vital provisions to help increase access to evidence-based addiction treatment at a time of unprecedented need
Full story
-
Jun 14, 2022, 09:56
by
Bob Davis
On June 6th, the Pennsylvania Society of Addiction Medicine (PSAM) sent a letter to state lawmakers in support of SB 926. This legislation would legalize the operation of syringe service programs (SSPs) statewide. Under current law, it is still illegal to open a SSP in most parts of Pennsylvania.
Full story
-
Jun 6, 2022, 04:00
by
Bob Davis
Our organizations write to express our deep concerns about false and harmful attempts to link mental illness and gun violence. The horrific school shooting in Uvalde, Texas that killed 19 children and two adults on May 24th is just one in a long series of mass shootings throughout our country.
Full story
-
Jun 3, 2022, 08:32
by
Bob Davis
ASAM joined a large coalition of public health, harm reduction, HIV, and hepatitis organizations in sending a letter urging Congress to appropriate $150 million in fiscal year 2023 towards the Centers for Disease Control and Prevention’s (CDC) Infectious Diseases and Opioid Epidemic Program.
Full story
-
May 18, 2022, 14:13
by
Bob Davis
Inclusion of Provisions Reflected in the Medication Access and Training Expansion (MATE) Act (H.R. 2067) and the Mainstreaming Addiction Treatment (MAT) Act (H.R. 1384) will help expand and mainstream addiction medicine.
Full story
-
May 12, 2022, 14:59
by
Bob Davis
On May 11th, the Louisiana Society of Addiction Medicine (LSAM) sent a letter to members of the House Committee on Health and Welfare in support of SB 268. This legislation would require opioid treatment programs (OTPs) to provide medication for opioid use disorder (MOUD) to pregnant women.
Full story
-
May 11, 2022, 17:00
by
Bob Davis
On May 11th, ASAM and other stakeholders sent a letter to U.S. House Energy and Commerce Committee leadership praising Section 321 of the Restoring Hope for Mental Health and Well-Being Act of 2022
Full story
-
May 10, 2022, 12:00
by
Bob Davis
On May 10th, ASAM sent a letter[KMC1] to leadership of the U.S. House Committee on Energy and Commerce on H.R. 7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 (the “Act”), in advance of the Subcommittee on Health’s legislative mark-up session on May 11th.
Full story
-
May 10, 2022, 09:41
by
Bob Davis
On May 9th, the Louisiana Society of Addiction Medicine (LSAM) sent a letter to members of the Senate Committee on Judiciary C expressing support for HB 212.
Full story